MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Venture Capital: Risk Capital_Angel, Venture, Sovereign Wealth Investor Companies & Organizations
Keiretsu Forum
Industry: Silicon Valley, California
Transcend Medical
Attachments
Company
Parents
*Portfolio Companies: Finistere Partners
Architects: Ophthalmology, Optometry & Ocular Health (Health IT, Devices & Technology)
Industry: Silicon Valley, California
Venture Capital: Series B
Children
2009: TRANSCEND MEDICAL RAISES $35 MILLION SERIES B ROUND TOWARDS DEVELOPMENT OF NOVEL GLAUCOMA TREATMENT (2009)
2011: Transcend Medical raises $51M Series B for glaucoma study | Silicon Valley (2011)
2014: Transcend Medical raises $22M for glaucoma treatment device_bizjournals
Eugene de Juan, Jr., M.D., Jean Kelly Stock Distinguished Professor of Ophthalmology at UCSF and Founder of Transcend Medical
Ike Ahmed, M.D., Assistant Professor, University of Toronto who is a world renowned glaucoma specialist and a clinical investigator of the CyPass System
Lead investor HLM Venture Partners, Canaan Partners, Technology Partners and Latterell Venture Partners, Morgenthaler Ventures, Split Rock Partners.
Menlo Park, California
Transcend CyPass™ System, a novel proprietary system for the minimally-invasive treatment of glaucoma
Transcend Medical is focused on a less invasive procedure using a novel, proprietary system that reduces intraocular pressure (IOP).
Jumps
ForSight Labs
UCSF (University of California San Francisco)